Clinical Trial Update: Study to Evaluate the Safety, Tolerability, Efficacy, and PK of FHL-301 in Parkinson's Disease Patients. [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the safety, tolerability, efficacy, and pharmacokinetics of FHL-301 in Parkinson's disease is planned but not yet recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• FHL-301

Snippet

Sponsor: Forest Hills Lab | Conditions: Parkinson Disease | Phase 2 | Status: NOT_YET_RECRUITING